HELP insider trading
NasdaqGM HealthcareCYBIN INC: insider trade history from SEC Form 4 filings.
About CYBIN INC
Cybin Inc., doing business as Helus Pharma, a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.
Company website: cybin.com
HELP insider activity at a glance
FilingIQ tracks 3 insider transactions for HELP in filings since Oct 1, 2026. The most recent transaction is dated Sep 30, 2026.
Across the full history, 1 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on HELP insider trades is 63.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest HELP Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading HELP
Frequently asked
- How many insider trades does FilingIQ track for HELP?
- FilingIQ tracks 3 Form 4 insider transactions for HELP (CYBIN INC), covering filings from Oct 1, 2026 onwards. 3 of those are dated within the last 90 days.
- Are HELP insiders net buyers or net sellers?
- Across the full Form 4 history for HELP, 1 transactions (33%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does HELP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is HELP in?
- CYBIN INC (HELP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $339.78M.
Methodology & sources
Every HELP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.